Peptides are on more skincare labels than ever. They appear in serums, eye creams, moisturisers, cleansers, and SPFs across every price point. Most of these products do not deliver meaningful peptide results. The ingredient is listed, the label is accurate, and the product does not work the way the marketing suggests it will. Understanding why this gap exists is the most useful thing you can know before spending money on anything calling itself a peptide product.
Problem 1: Listed but not dosed
Ingredient lists are required by regulation to list every ingredient present in a formula, in descending order of concentration. They are not required to disclose how much of each ingredient is present. A peptide can appear on an ingredient list at 0.0001% — a trace quantity with no biological activity at the concentrations used in clinical research — and the label is still accurate and compliant.
This is why the position of a peptide on an ingredient list matters significantly. If it appears near the bottom of a long list, after preservatives, fragrance components, and botanical extracts, it is almost certainly present at a concentration below what clinical studies used to demonstrate efficacy. The peptide is technically present. It is not present in a form that will produce meaningful results.
For signal peptides like Matrixyl (Palmitoyl Pentapeptide-4), clinical research demonstrating measurable collagen stimulation has used concentrations in the range of 3 to 10 parts per million. Formulas at lower concentrations show no statistically significant effect in controlled settings. A product listing Matrixyl as the 28th ingredient in a 30-ingredient formula is not a peptide product in any meaningful sense.
Problem 2: No delivery system
Getting a peptide from a serum to the fibroblasts where it does its work requires it to cross the skin barrier — which is specifically designed to prevent external substances from reaching those layers. Peptides are relatively large hydrophilic molecules; the skin barrier is a lipid-rich structure that favours small, lipid-soluble molecules. Without formulation engineering to address this mismatch, most of a peptide applied to the skin surface stays there and gets wiped off at the next cleanse.
The formulation solutions are not cheap: lipid carriers, encapsulation technology, molecular weight optimisation, pH calibration. Palmitoylation — attaching a fatty acid to a peptide molecule — is one of the most well-documented approaches: it makes the peptide more lipid-soluble and significantly improves skin penetration. This is why several of the best-evidenced peptides in skincare have names starting with Palmitoyl: Palmitoyl Tripeptide-1, Palmitoyl Pentapeptide-4, Palmitoyl Tetrapeptide-7. The palmitoyl group is not decorative. It is the delivery mechanism.
A formula that lists a generic peptide without palmitoylation or equivalent penetration engineering is relying on passive diffusion to deliver an ingredient that passive diffusion handles very poorly. The peptide sits on the skin surface and does nothing useful.
Problem 3: Wrong pH environment
Peptides are pH-sensitive. Their biological activity depends on maintaining specific charge states that are pH-dependent, and their penetration through the skin barrier is also pH-affected. Formulas that include peptides alongside highly acidic actives — vitamin C at pH 2.5 to 3.5, AHAs at pH 3 to 4 — create an environment that partially denatures or inactivates the peptide before it can reach the skin.
This is one of the practical reasons that peptide-only serums, or peptide formulas paired with non-acidic supporting ingredients, outperform mixed peptide-plus-acid formulas on measurable outcomes. The peptide is functional in the formula. The acid degrades its activity before it reaches the skin.
Problem 4: Instability and degradation
Peptides can degrade during product storage if the formula is not properly stabilised. Exposure to light, heat, and oxygen can break down peptide chains into shorter fragments that no longer carry the correct biological signal. In Singapore's ambient temperatures — consistently 28 to 32 degrees Celsius — product degradation rates are measurably faster than in temperate markets where most formulations are developed and stability-tested.
This means that a peptide product that was effective when manufactured may be significantly less effective by the time it has been shipped to Singapore, stored in a distribution warehouse, sat in a retail outlet, and then stored at room temperature in a Singapore home. The ingredient was once present and functional. By the time it reaches your skin, it may not be.
Airless pump packaging, UV-protective dark glass, and formulation preservatives that prevent oxidation all address this. They all add cost. They are present in well-formulated peptide products and absent in most low-price-point ones.
Problem 5: Single-peptide formulas addressing a multi-mechanism problem
Skin ageing is not caused by a single deficit. It involves declining collagen synthesis, increasing collagen degradation, elastin fragmentation, slowing cell renewal, barrier lipid depletion, and accumulating UV damage. A single peptide, however well-formulated, addresses one or two of these pathways. The others continue unaddressed.
This is why single-peptide products frequently produce limited results even when the peptide is properly dosed and delivered: the product is treating one pathway of a six-pathway problem. The other five are still running.
Multi-peptide formulas that combine signal peptides, neurotransmitter-inhibiting peptides, repair-signalling peptides, and barrier-supportive ingredients address the problem at the level at which it actually exists. They are more complex and more expensive to formulate. They are also substantially more effective at producing the visible changes that single-pathway products cannot.
What separates AURA LIFT from a peptide-labelled product
AURA LIFT's formula addresses each of the failure modes above specifically:
- Concentration: active peptides are positioned in the formula at biologically meaningful concentrations, not as trace label ingredients
- Delivery: palmitoylated peptides (Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7) with the lipid carrier required for effective skin penetration
- pH environment: the formula is designed to maintain a skin-compatible pH that preserves peptide activity, without the acid environment that degrades peptide function
- Stability: formulated and packaged for stability in tropical ambient temperatures
- Multi-mechanism: signal peptides, a neurotransmitter-inhibiting peptide (Acetyl Hexapeptide-8), a repair-signalling peptide (Copper Tripeptide-1), and barrier-supportive centella asiatica TECA addressing the ageing process at multiple simultaneous pathways
The test for any peptide product is not whether peptides are on the label. It is whether they are present at meaningful concentrations, delivered in a form that reaches the dermis, in a formula that keeps them active, addressing the problem at the level of complexity it actually exists at.
Peptides on a label is not the same as peptides in your skin.
The gap between the two is formulation, concentration, delivery, and stability. Most products do not bridge that gap. The ones that do produce results that make the distinction obvious.
0 comments